Scientific Sessions/Tracks

Session 1: Industrial Biotechnology:

IndustrialBiotechnology is a set of practices that uses livingcells such as bacteria, yeast, algae or components of the cells like enzymes togenerate the products of industrial importance. It is often referred to as the "Thirdwave" in biotechnology. It is one of the most favourableprocesses/method to control some of the serious issues of modern industry. Ifit is developed to its full extent it may have a larger impact on world than healthcareand agricultural biotechnology.  This session will include the recent advancesand research which entitles to use renewable raw materials and can contributeto lowering greenhouse gas emissions and stirring away from apetrochemical-based economy.

Session 2: Bioprocessing:

Bioprocessingforms the backbone of translating discoveries of life sciences into usefulindustrial product .The most renowned growth drivers in the global bioprocesstechnology market are the significant expansion in the biopharmaceuticalindustry, increasing thrust on research and development, higher demandfor vaccine,and progress in the field of technology. Innovation in new techniques will lead to bio-manufacturingindustries for a better circular bio economy. 

Session 3: Enzyme and microbial technology:

Enzymetechnology is one of the corner stones ofIndustrial Biotechnology. Rapid technological developments are now stimulatingthe chemistryand pharmaindustries to embrace enzyme technology, a trend. Microbialbiotechnology is defined as any empirical application that usesmicrobiological systems, microbial organisms or their derivatives, tomanufacture or modify products or processes for specific uses.  The development of rapid and affordablegenomics technologies and accompanying bioinformatics tools, and of highresolution analytical and imaging instruments, has provided new impulses to thefield and opened new avenues of application, one of which is micro-biomeengineering.

Session 4: Bio-based products:

IndustrialBiotechnology uses enzymes to make bio-based productslike chemicals, ingredients, detergents, materials and biofuels. Since thattime, industrial biotechnology has produced enzymes for use in our daily livesand for the manufacturingsector.

Session 5: Bio-catalysis:

Bio-catalysiscanbe explained as the use of natural products like one or more enzymes or cellsto speed up (or catalyse) chemical reactions. The success of bio-catalysisdepends on protein engineering, enzyme immobilization. Immobilizationcan play an important role in the adoption of bio-catalytic processes. Byswitching to bio-catalysis as the main technology for chemical production, itwill lead to green processing, reduces pollution and cost, and help towards bio-economy.Bio-catalysis will help in increasing the ability to use enzymes to catalysechemical reactions in industrial biotechnology.

Session 6: Biomaterials:

Biomaterialsplay an important role in medicineindustry including heart valves, stents, and grafts; artificial joints,ligaments, and tendons; hearing loss implants; dental implants; and devicesthat stimulate nerves. The recent advances of biomaterials combine medicine,biology, physics, and chemistry, and more recent fields are from tissueengineering and materialsscience. Biomaterials foundtheir application in various fields like in dental applications, surgery, anddrug delivery.

Session 7: Bioenergy and Bio-renewables:

Bioenergy and Bio-renewablesoffers a solution for the production of renewable energy from biodegradablesources, such as wastes from municipal, food, agricultural and biomass.  BioenergyResearch fills a void in the rapidly growing area of feedstock biology researchrelated to biomass, biofuels, and bioenergy. There are three main categories ofbio-renewable resources: food, bio-products, and bioenergy. The use of biomassenergy can minimize our greenhousegas emission, it’s feed stockscan also help in making profits for the agricultural industry.

Session 8: Bioreactor design and Scale-up:

The design ofthe bioreactor plays a major role in the functioning of the bioprocessand upstreamprocessing. The simple designmakes it possible to control the degree of shear uniformly within a reactor(critical to cell growth). For commercializing the product scale up of thebioreactor is very important. The success of the process hinges, to a limit, onensuring the designing aspects in bioreactor and the operational procedures.

Session 9: Bioplastics and Biopolymers:

Bio-plasticscanhelp reduce reliance on fossil fuels, support sustainability in the industryand allow manufacturers to diversify feedstock. Biopolymershowever are the distinctive classification of the group of materials underwhich bio-plastics are also included. Plastics are replaced with bio-plastics,since they pollute our environment, pose a danger to wildlife and they do notdegrade quickly. But new research findsbio-plastics are just as toxicas ordinary plastics. Bio-based and biodegradable plastic is no safer thanother plastic. This session deals with the latest works and news about thebio-plastics.

Session 10: Synthetic Biology:

 Synthetic biologyresearchers and companies around the world are harnessing the power of natureto solve problems in medicine, manufacturing and agriculture. It is the basisfor the discovery and design of biological catalysts for industrialapplication. A unique ethical concern about synthetic biology is that it mayresult in the creationof entities which fall somewhere between living things and machines.

Session 11: Regenerative Medicine And Tissue Engineering:

Here by regenerativemedicines mean the bioprocess engineering area of stem cell tissueengineering including scale-upand scale-down.In the “whole bioprocessing” aspect the complete process starting from donor orpatient biopsy all the way through by clinical insertion to the patients.

Bioprocessingfor RegenerativeMedicine is an entirely new field, which can only be partially comparedwith that of mass production of molecularmedicines. Regenerative medicine and tissue engineering are one of thefastest growing areas of research in medical industries.

Session 12: Agri-food technology:

The agri-foodindustry has a significant role to play in food system, the motive of which isto feedpopulations, mostly through achain of market relationships. The food system within the agri-food industryvaries by country. Techniques like genetic engineering, molecular markers,molecular diagnostics, vaccines, and tissue culture, are utilized by agriculturalscience to alter the genes in living organisms including plants,animals, and microorganisms.

Session 13: Marine biotechnology:

MarineBiotechnology or bluebiotechnology securing industrial products and processes bysynthesizing proteins and enzymes and can also support new process innovationin the pharmaceutical and food industries or in molecular biology anddiagnostic kits. Marine biotechnology may include techniques such asbioprocessing, bio-harvesting, bio-prospecting, bioremediation, usingbioreactors. The new applications of marine derived enzymes are found to be inthe beautyindustry and use of algae and micro algae in biofuelproduction.

Session 14: Cell therapy bioprocessing and commercialization:

Cell &Gene Therapy Bioprocessing & Commercializationoptimize the process, manufacturing capabilities and analytical strategies,accelerate preclinicalstudies and push products into the clinic with case studies fromleading companies. They develop successful clinical strategies and regulatoryintelligence for efficient development with benchmarking opportunities,and much more.

Session 15: Algal Technologies:

Algae arethe ‘greengold’ of the future bio-economyas they became a valuable and sustainable feedstock for numerous industriescontributing to the bio-sustainability. Their application varies from biofuels,food additives, animal feed, novel food, bio-plastics, cosmetics,bio-fertilizers or CO2 utilization and many more. The market is rapidlyexpanding, and it is still not reached its full potential. Scientists areworking on newtechnologies and costoptimization to scale up pilot projects to industrial production for a better greenand clean future.

Session 16: Bioremediation and Waste Treatment:

A treatment managementsystem that uses natural organisms to remove or neutralize pollutants andcovert into less toxic or non-toxic substances called bioremediation. For asuccessful and effective bioremediation, the system needs a correct balanceof the favourable temperature and nutrient content. It is a cost-effective method when compared toother clean up techniques, as it does not need a great deal of equipment orlabour.

Session 17: New IB tools and technologies:

The industrialization of biology offers far-reachingbenefits at both the globaland the nationalscale. Today, the focus is to improve efficacy and robustness ofmicrobial cell factories, suitable for industrial production of products inhealth industry and others.Strain engineering is to be doneto improve the existing either by mutagenesis or advanced targeted methods. IfIndustrial Biotechnology is used to its full potential, it would be the besttool towards a sustainablebio-economy.

Session 18: Bio-economy and Circular economy:

The circulareconomy is a model of production and consumption, which involvessharing, leasing, reusing, repairing, refurbishing and recycling existingmaterials and productsas long as possible. It avails gradually decouplingeconomic activity from the consumption of finite resources anddesigning waste out of the system. Bio-economyis a understanding mechanism and processes at the genetic and molecular levelsand applying this understanding towards the globalsustainability.

Related: IndustrialBiotechnology Conferences | IndustrialBiotechnology and Bioprocessing Conferences | BiotechnologyMeetings | BioprocessingEvents | Bioenergy Conference

Related Societies and Associations:

Europe: YoungEuropean Network (YEBN), European Federation of Pharmaceutical Industriesand Associations (EFPIA), EuropeanBio-Pharmaceutical Enterprises (EBE), BiotechnologyIndustry Organizations (BIO), EuropeanAssociation of Pharma Biotechnology (EAPB), DANKSBIOTEK,DanishBiotechnology Society, NovoNordisk Foundation Centre for Bio Sustainability, Bio-Businessand Innovation Platform, IrishBio-Industry Association (IBIA).

USA: BiotechnologyInnovation Organization (BIO), SwissBiotech Association, Massachusetts BiotechnologyCouncil, Association of Biotechnology Led Enterprises (ABLE), IllinoisBiotechnology Innovation Organization (BIO), Society for Industrial Microbiology and Biotechnology(SIMB).
 

Asia-Pacific: Asian Federation ofBiotechnology (AFOB), Federation of Asian Biotech Association (FABA), Bio-Asia.

Market Analysis

U K: Biotechnology companies account for 35% of drug development products in the UK and 41% of new drug development in stage clinical trials. London is one of the biggest hubs
for biotechnology companies in Europe
for biotechnology companies in Europe. Increasing government investment in research and development (R&D) is anticipated to prove particularly beneficial in the coming years. 

Asia-Pacific: The Asia-Pacific biotech market has expanded with a compound annual growth rate (CAGR) of around 16% during2010-2012. It has been found that Japan and China are controlling this industry, while countries like Malaysia, India, and Singapore are also in the limelight and are looking forward to dominating around 70% of the global market.

Europe: A prosperous bio-based European economy is mainly because of the industrial biotechnology sector and more than 60% of the world’s enzymes, has been produced, thus making Europe, a world leader in the industrial biotechnology field. The major countries in the European Union that came up in this sector included  Denmark, Germany, Netherlands, France, UK, and Sweden.